Journal of the American Heart Association

FEBRUARY 29, 2024

BackgroundAnnual heart transplant (HT) volumes have increased, as have post‐HT outpatient care needs. days), and comorbidity burden was high: 42% had hypertension, 38% had diabetes, and 31% had ≥2 comorbidities. Journal of the American Heart Association, Ahead of Print. Length of stay was 3.1 days (interquartile range, 1.6–5.9

Heart Transplant 40

Heart Transplant Transplant Hospital Outpatient 40

Open Heart

NOVEMBER 14, 2023

Methods We used the Swedish Registry of Cardiopulmonary Resuscitation, merged with the Inpatient Registry and Outpatient Registry to identify patients with OHCA from 2010 to 2020 and to collect all their comorbidities as well as discharge diagnoses (among those admitted to hospital). had type 2 diabetes, compared with 19.6% of the men.

Cardiac Arrest 52

Cardiac Arrest Coronary Artery Disease Hospital Heart Failure 52

European Journal of Heart Failure

SEPTEMBER 26, 2023

Validated cut-points are provided to rule in or rule out acute heart failure in the emergency department and to diagnose de novo heart failure in the outpatient setting. diabetes, hypertension, coronary artery disease), underlying the development of cardiac dysfunction and further increased risk.

Heart Failure 40

Heart Failure Coronary Artery Disease Outpatient Document 40

Circulation: Cardiovascular Quality & Outcomes

NOVEMBER 6, 2023

0.96]) decreased for low-income adults, while diabetes screening (RR 1.01 [0.95-1.08]) 1.08]) increased and diabetes focused visits and insulin use remained stable. However, routine outpatient visits and cardiovascular risk factor screening did not return back to pre-pandemic levels, while risk factor treatment remained stable.

Risk Factors 40

Risk Factors Medicaid COVID-19 Outpatient 40

Hypertension Journal

DECEMBER 11, 2023

METHODS:The J-HOP study enrolled outpatients with ≥1 cardiovascular risk factor between 2005 and 2012, with follow-up until March 2015 and extended follow-up from December 2017 to May 2018. Findings were similar in the subgroup of high-risk patients (those with diabetes or stroke history).CONCLUSIONS:These

Blood Pressure 40

Blood Pressure Coronary Artery Disease Cardiovascular Disease Heart Failure 40

Open Heart

JULY 20, 2022

Outcome measures were (1) all-cause hospitalisations, (2) outpatient clinic attendances and (3) cost. Multispecialty interventions included optimising diabetes therapy (haemoglobin A1c-HbA1c pre-MDT 68±11 mmol/mol vs post-MDT 61±9 mmol/mol; p<0.001), deprescribing to reduce anticholinergic burden (pre-MDT 1.85±0.4

Heart Failure 52

Heart Failure Kidney Disease Outpatient Nursing 52

DAIC

APRIL 30, 2024

The drug, dapagliflozin, was initially approved for the treatment of Type 2 diabetes, but it since has been shown to reduce the risk of hospitalization for heart failure and death in patients with serious health problems that include heart and chronic kidney disease and heightened cardiovascular risk.

Heart Failure 105

Heart Failure Hospital Research COVID-19 105

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

His presentation raised concern for etiology such as vasculitis or multiple sclerosis and prompted a genetic workup, which was obtained on outpatient follow‐up. He had a documented history of transient‐ischemic attack and was noted to have undergone progressive cognitive decline.

Arterioles 40

Arterioles Cerebrovascular Disease Outpatient Document 40

Open Heart

SEPTEMBER 27, 2023

Background Heart failure (HF), type 2 diabetes (T2D) and chronic kidney disease (CKD) commonly coexist. Inpatient and outpatient healthcare utilisation rates were highest in CKD and HF, and lowest in CKD and T2D. We studied characteristics, prognosis and healthcare utilisation of individuals with two of these conditions.

Risk Factors 52

Risk Factors Kidney Disease Heart Failure Diabetes 52

DAIC

APRIL 6, 2024

SGLT-2 inhibitors were initially approved to treat Type 2 diabetes by lowering blood sugar. About 32% had Type 2 diabetes. This finding is completely consistent in both direction and magnitude with other studies of SGLT-2 inhibitors in populations with diabetes and chronic kidney disease.”

Heart Attack 98

Heart Attack Heart attacks Heart Failure Outpatient 98

DAIC

APRIL 6, 2024

SGLT-2 inhibitors were initially approved to treat Type 2 diabetes by lowering blood sugar. About 32% had Type 2 diabetes. This finding is completely consistent in both direction and magnitude with other studies of SGLT-2 inhibitors in populations with diabetes and chronic kidney disease.”

Heart Attack 81

Heart Attack Heart attacks Heart Failure Outcomes 81

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Study Population includes all patients with an ischemic stroke inpatient admission in 2018 and were continuously enrolled with Medicare FFS for 1 year prior to and following their initial 2018 stroke admission. 1.378]), and heart failure (1.282 [95%CI, 1.25‐1.315]).ConclusionPatient

Risk Factors 40

Risk Factors Stroke Strokes Medicare 40

Dr. Smith's ECG Blog

NOVEMBER 12, 2020

Higher troponin correlated with more history of heart failure, diabetes, and hypertension, as well as higher D-dimer, and nearly all inflammatory markers. Median age was 66.4 were over age 70, and 60% were men. CV disease was more prevalent in those with higher troponin.

Cardiac Arrest 52

Cardiac Arrest COVID-19 Myocardial Infarction Cardiogenic Shock 52

Dr. Smith's ECG Blog

APRIL 6, 2023

Medical history: History of Ischemic Heart Disease History of Congestive Heart Failure Diabetes Mellitus requiring treatment with insulin Pre-operative serum creatinine >2 mg/dL He had this ECG recorded: What do you think? If the patient does not present with syncope, then outpatient management is probably OK, with referral to cardiology.

Atrial Fibrillation 52

Atrial Fibrillation Arrhythmia Outpatient AFIB 52